Abstract:Ganoderma triterpenoids (GTs), a class of major active constituents in Ganoderma species, play an important role in the anti-obesity effect of Ganoderma fungi. In the study, seventeen new highly oxygenated lanostane triterpenoids, ganoapplanoids A–Q (1–17), together with five previously reported compounds (18–22), were isolated from the fruiting bodies of Ganoderma applanatum. Their structures were confirmed by comprehensive spectroscopic analyses, single-crystal X-ray diffraction and Mo2(OAc)4 induced CD cotton effect. Structurally, compound 6 represents the first example of 2-norlanostane triterpenoid possessing an unusual semiacetal moiety. Furthermore, isolates (1–5, 7–11, 13–22, 3a) were evaluated for regulatory effects on lipid accumulation by 3T3-L1 adipocytes model. Among them, compounds 11 and 17 exhibited significant potency in blunted adipogenesis activities dose-dependently. Meanwhile, compounds 11 and 17 reduced triglyceride (TG) and total cholesterol (TC) levels in the adipocytes. These results supported that the highly oxygenated lanostane triterpenoids from G. applanatum may serve as agents for inhibiting the lipid accumulation in adipocytes and the G. applanatum provided an important source for searching new drugs to treat obesity.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is effective treatment methods for obesity and its related metabolic diseases. Specifically, researchers isolated a series of highly oxygenated lanostane - type triterpenoids from *Ganoderma applanatum* and evaluated the inhibitory effects of these compounds on lipid accumulation in adipocytes. Obesity is a global public health problem and is closely related to multiple diseases such as insulin resistance, type 2 diabetes, hyperlipidemia, non - alcoholic fatty liver disease and cardiovascular diseases. Although lifestyle changes (such as diet and exercise) can effectively control obesity, they are more difficult to implement and difficult to sustain. In contrast, drug treatment is a faster and more effective way to combat obesity. However, currently only two drugs are approved for long - term treatment of obesity in the US market. Therefore, it is of great significance to search for new anti - obesity drugs. In this study, researchers isolated 17 new highly oxygenated lanostane - type triterpenoids (ganoapplanoids A - Q) and 5 known compounds from the fruiting bodies of *Ganoderma applanatum*. The regulatory effects of these compounds on lipid accumulation were tested through the 3T3 - L1 pre - adipocyte model. The results showed that compounds 11 and 17 exhibited significant dose - dependent anti - adipogenic activities and could reduce the levels of triglyceride (TG) and total cholesterol (TC) in adipocytes. These results support the possibility of highly oxygenated lanostane - type triterpenoids as potential drug candidates for inhibiting lipid accumulation in adipocytes and also indicate that *Ganoderma applanatum* is an important source for finding new drug sources for treating obesity.

Highly oxygenated lanostane triterpenoids from Ganoderma applanatum as a class of agents for inhibiting lipid accumulation in adipocytes

Functional triterpenoids from medicinal fungi Ganoderma applanatum: A continuous search for antiadipogenic agents

Anti-Adipogenic Lanostane-Type Triterpenoids from the Edible and Medicinal Mushroom Ganoderma applanatum

Identification of a Novel Metabolic Target for Bioactive Triterpenoids Biosynthesis in <i>Ganoderma</i> lucidum

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

New lanostane-type triterpenoids with proangiogenic activity from the fruiting body of Ganoderma applanatum

Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH

Twelve undescribed derivatives of ganoderic acid isolated from Ganoderma luteomarginatum and their cytotoxicity against three human cancer cell lines

Lanostane Triterpenoids and Ergostane Steroids from Ganoderma luteomarginatum and Their Cytotoxicity

Applanaic acids A–C, three new highly oxygenated lanostane triterpenoids from the fruiting bodies of Ganoderma applanatum

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

FPR2-based anti-inflammatory and anti-lipogenesis activities of novel meroterpenoid dimers from Ganoderma